thienopyrimidinone

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

1.	Amanzougaghene, Nadia: 1 article (10/2021)
2.	Ashraf, Kutub: 1 article (10/2021)
3.	Azas, Nadine: 1 article (10/2021)
4.	Benoit-Vical, Françoise: 1 article (10/2021)
5.	Bosson-Vanga, Henriette: 1 article (10/2021)
6.	Cohen, Anita: 1 article (10/2021)
7.	Dereuddre-Bosquet, Nathalie: 1 article (10/2021)
8.	Donnette, Mélanie: 1 article (10/2021)
9.	Franetich, Jean-François: 1 article (10/2021)
10.	Gomez, Lina: 1 article (10/2021)

1.	Obesity 09/25/2014 - "We report the SAR evolution of hydroxylated thienopyrimidinone ethers culminating in the identification of 27 (BMS-819881), which entered obesity clinical trials as the phosphate ester prodrug 35 (BMS-830216). "
2.	Neoplasms (Cancer) 06/17/2019 - "In this work, we have studied the anti-cancer activity of the synthesized thienopyrimidinone derivatives against MCF-7 and MCF-10A cancer cells. " 06/17/2019 - "In this study, some of new thiophenyl thienopyrimidinone derivatives 2-15 were prepared and tested as anti-cancer agents by using thiophenyl thieno[2,3-d]pyrimidinone derivative 2 as a starting material, which was prepared from cyclization of ethyl ester derivative 1 with formamide. "
3.	Malaria 10/31/2021 - "These results highlight the thienopyrimidinone scaffold as a novel antiplasmodial chemotype of great interest to search for new drug candidates displaying multistage activity and an original mechanism of action with the potential to be used in combination therapies for malaria elimination in the context of artemisinin resistance. "

1.	Therapeutics